hotspot -WSS

hotspot

author：focus 2025-10-02 22:57:56 - browse：69175

When Prozac first entered the psychiatry scene in in the late ’80s, the profession was still Freud’s territory. Many considered taking medication to treat depression a failure. But that was all about to change, as early stewards like psychiatrist Peter Kramer refused to shy away from the new drug’s potential. These days, he says that people take for granted all of the progress that’s been made with antidepressant treatment in the past three decades.

“If you were going to be depressed any time in history and were interested in having an effective treatment, you would want to be alive now. But we’ve lost our wonderment about that,” said Kramer, the author of the groundbreaking 1993 book “Listening to Prozac.”

This week, Kramer joins me to discuss how the country’s relationship with antidepressants has changed since the publication of his book three decades ago. The conversation is based on his First Opinion, “What antidepressants are saying 30 years after the publication of ‘Listening to Prozac.’”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Medicare Advantage insurers pressure Biden for bigger payments

focus

WSS

3 questions for the future of Biden's cancer moonshot

Analysis of telehealth claims data suggest service duplication

Chan Zuckerberg Biohub Chicago to focus on inflammation

FDA rejects Alnylam's heart disease treatment over insufficient data

Was Amgen transparent enough on FDA's concern on cancer drug?

What to expect at HLTH 2023, the health care industry conference

focus

hotspot

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Medicare Advantage insurers pressure Biden for bigger payments

Medical leaders decry Supreme Court decision on affirmative action

6 surprising facts about sugar

Supreme Court strikes down use of affirmative action

Readout LOUD podcast, live from the STAT Breakthrough Summit East

The high cost of giving birth even with insurance

Asbestos ban is immediate, but health effects will linger for decades

23andMe had bad news about my health. I wish a person had delivered it

FDA rejects Alnylam's heart disease treatment over insufficient data

Wikipedia

VC firm General Catalyst wants to buy a health system

The future of health care in the House

Bring on the sabbaticals for nurses

Cancer, immunology, HIV research ensnared in fetal tissue politics

Adam's Take: Intra

This gene therapy has record $4.25 million price. It's saved children.

focus

leisure time

focus

hotspot